Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Product
Tóm tắt
Two 54-year-old women developed abdominal cramps and vaginal hemorrhage as a result of endometrial hyperplasia during treatment with a hop-containing phytotherapeutic product (MenoCool®) for post-menopausal complaints. The women used the hop-containing phytotherapeutic product (418 mg of hop per tablet) twice daily (1 and 0.5 tablets by both patient A and B). Patient A developed abdominal cramps and vaginal hemorrhage after 2 months of use. After gynecological examination, she was diagnosed with endometrial hyperplasia. The patient was treated with a curettage. The hop-containing phytotherapeutic product was discontinued, and the patient recovered. Patient B developed abdominal pain/cramps and vaginal hemorrhage after 5 months of use. A cervix smear, internal examination, and ultrasound were performed. Due to the thickness of the endometrium, a pipelle endometrial biopsy was performed. Results showed no indication for cervix cancer. The use of MenoCool® was ceased; follow-up information received from the patient shortly thereafter indicated that she had almost entirely recovered from the abdominal pain/cramps and vaginal hemorrhage. Hop (Humulus lupulus) has phytoestrogenic properties that may be the cause of endometrial hyperplasia and subsequent vaginal hemorrhage. A Naranjo assessment score of 5 was obtained for both cases, indicating a probable relationship between the patient’s endometrial proliferation and subsequent vaginal hemorrhage and their use of the suspect drug.
Tài liệu tham khảo
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.
Poluzzi E, Piccinni C, Raschi E, Rampa A, Recanatini M, De PF. Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective. Curr Med Chem. 2014;21(4):417–36.
Nettekoven M. Menopauze vaker met hormonen te lijf, Ondergebruik is onnodig. Pharm Weekbld. 2012;147(5):14–17.
Kurzer MS. Phytoestrogen supplement use by women. J Nutr. 2003;133(6):1983S–6S.
Milligan S, Kalita J, Pocock V, Heyerick A, De CL, Rong H, et al. Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin. Reproduction. 2002;123(2):235–42.
Overk CR, Yao P, Chadwick LR, Nikolic D, Sun Y, Cuendet MA, et al. Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J Agric Food Chem. 2005;53(16):6246–53.
van Hunsel FP, Kampschoer P. Postmenopausal bleeding and dietary supplements: a possible causal relationship with hop- and soy-containing preparations. Ned Tijdschr Geneeskd. 2012;156(41):A5095.
Micromedex® 1.0 (Healthcare Series). Detailed evidence-based information (DRUGDEX®) norethisterone. http://www.micromedexsolutions.com/. 2015 [cited 19 Mar 2015].
UpToDate®. Postmenopausal uterine bleeding. http://www.uptodatecom/contents/postmenopausal-uterine-bleeding?source=machineLearning&search=postmenopausal+bleeding&selectedTitle=1%7E33§ionRank=1&anchor=H15#H15. 2015 [cited 1 Feb 2015]. Available from: http://www.uptodate.com.
Astrup K, Olivarius NF. Frequency of spontaneously occurring postmenopausal bleeding in the general population. Acta Obstet Gynecol Scand. 2004;83(2):203–7.
Furness S, Roberts H, Marjoribanks J, Lethaby A. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev. 2012;8:CD000402.
Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril. 2004;82(1):145–8.
Chadwick LR, Pauli GF, Farnsworth NR. The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. Phytomedicine. 2006;13(1–2):119–31.
Milligan S, Kalita J, Pocock V, Heyerick A, De CL, Rong H, et al. Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin. Reproduction. 2002;123(2):235–42.
Tekel’ J, De KD, Rong H, Daeseleire E, Van PC. Determination of the hop-derived phytoestrogen, 8-prenylnaringenin, in beer by gas chromatography/mass spectrometry. J Agric Food Chem. 1999;47(12):5059–63.
Meagher LP, Beecher GR. Assessment of data on the lignan content of foods. J Food Compost Anal. 2000;13(6):935–46.
Kuhnle GG, Dell’aquila C, Aspinall SM, Runswick SA, Mulligan AA, Bingham SA. Phytoestrogen content of cereals and cereal-based foods consumed in the UK. Nutr Cancer. 2009;61(3):302–9.
Ososki AL, Kennelly EJ. Phytoestrogens: a review of the present state of research. Phytother Res. 2003;17(8):845–69.
Guerrero JA, Lozano ML, Castillo J, Benavente-Garcia O, Vicente V, Rivera J. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J Thromb Haemost. 2005;3(2):369–76.
PhytoGeniX. PhytoGeniX projects—Menocool. http://www.phytogenixnl/the-company/phytogenix-projects/. 2014 [cited 8 Jan 2015]. Available from: http://www.phytogenix.nl.
Schmitz SM, Lopez HL, MacKay D. Nutravigilance: principles and practices to enhance adverse event reporting in the dietary supplement and natural products industry. Int J Food Sci Nutr. 2014;65(2):129–34.
Walji R, Boon H, Barnes J, Austin Z, Welsh S, Baker GR. Consumers of natural health products: natural-born pharmacovigilantes? BMC Complement Altern Med. 2010;10:8.
van Hunsel F, Harmark L, Pal S, Olsson S, van Grootheest K. Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf. 2012;35(1):45–60.
DuSart Pharma. DuSart Pharma website. http://www.dusartpharma.com/Default?lang=EN. 2015 [cited 28 July 2015]. Available from: http://www.dusartpharma.com.
USA Food and Drug Administration (FDA). Hazard Analysis & Critical Control Points (HACCP). http://www.fda.gov/Food/GuidanceRegulation/HACCP/. 2015 [cited 28 Sept 2015]. Available from: http://www.fda.gov/.
Scholtens B. Studie naar borstvergrotende pil. Algemeen Dagblad (AD). 6 Dec 2003. Sect. Geld>producten.
van Calmthout M. De Wonderhop. De Volkskrant. 6 Jan 2001. Sect. Archive.
Unknown journalist. Online gevecht over voedingssupplement. Dagblad de Limburger. 8 Nov 2012. Sect. Economy.
Kievits F, Adriaanse MT. Wonderbaarlijke borstvergroting. Ned Tijdschr Geneeskd. 2003;147:2598–9.
Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med. 2006;144(5):364–7.